A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants

被引:19
|
作者
Li, Xuanyi [1 ]
Warner, Jeremy L. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA
[3] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA
关键词
precision oncology; knowledgebase; variant interpretation; actionability; targeted therapy; genotype-selective clinical trial; tumor genetic testing; OFF-LABEL USE; PRIVATE MUTATIONS; PHARMACOGENOMICS KNOWLEDGE; MEDICINE; GENOMICS; TRIAL; IDENTIFICATION; INFORMATION; PREVALENCE; LANDSCAPE;
D O I
10.3389/fcell.2020.00048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Year in review: Clinical implementation of whole genome sequencing in precision oncology
    Sunami, Kuniko
    CANCER SCIENCE, 2024, 115 : 704 - 704
  • [22] Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice
    Lin, Jianzhen
    Dong, Kun
    Bai, Yi
    Zhao, Songhui
    Dong, Yonghong
    Shi, Junping
    Shi, Weiwei
    Long, Junyu
    Yang, Xu
    Wang, Dongxu
    Yang, Xiaobo
    Zhao, Lin
    Hu, Ke
    Pan, Jie
    Sang, Xinting
    Wang, Kai
    Zhao, Haitao
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (18)
  • [23] Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support
    Chae, Young Kwang
    Pan, Alan P.
    Davis, Andrew A.
    Patel, Sandip P.
    Carneiro, Benedito A.
    Kurzrock, Razelle
    Giles, Francis J.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (12) : 2645 - 2655
  • [24] Precision Medicine and Rare Genetic Variants
    Lauschke, Volker M.
    Ingelman-Sundberg, Magnus
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (02) : 85 - 86
  • [25] Lipid related genetic variants panel for precision nutrition interventions: a systematic review
    Rivera-Iniguez, Ingrid
    Gonzalez-Becerra, Karina
    Elizabeth Perez-Beltran, Yolanda
    Sophia Chaguen-Hernandez, Marian
    Ramos-Lopez, Omar
    Mendivil Rangel, Edgar Jair
    ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 448 - 448
  • [26] Variants of uncertain significance in precision oncology: nuance or nuisance?
    Mellgard, George S.
    Atabek, Zoey
    LaRose, Meredith
    Kastrinos, Fay
    Bates, Susan E.
    ONCOLOGIST, 2024, 29 (08): : 641 - 644
  • [27] Annotation of variants of unknown significance on RET for precision oncology
    Nakaoku, Takashi
    Tabata, Junya
    Maruyama, Kosuke
    Kohno, Takashi
    CANCER SCIENCE, 2022, 113 : 368 - 368
  • [28] Resources for Interpreting Variants in Precision Genomic Oncology Applications
    Tsang, Hsinyi
    Addepalli, KanakaDurga
    Davis, Sean R.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [29] Challenges in heart failure: from actionability of genetic variants in cardiopmyopathies to new therapeutic targets
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2022, 43 (20) : 1887 - 1890
  • [30] Clinical translation of radiotheranostics for precision oncology
    Jingjing Zhang
    Tianzhi Zhao
    Vivianne Jakobsson
    Xiaoyuan Chen
    Nature Reviews Bioengineering, 2023, 1 (9): : 612 - 614